Multiple-Dose Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Subcutaneous Rusfertide, a Hepcidin Mimetic, in Healthy Subjects.

Saved in:
Bibliographic Details
Title: Multiple-Dose Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Subcutaneous Rusfertide, a Hepcidin Mimetic, in Healthy Subjects.
Authors: Modi NB; Protagonist Therapeutics, Inc., Newark, CA, USA., Dinh P; Protagonist Therapeutics, Inc., Newark, CA, USA., Ajari I; Protagonist Therapeutics, Inc., Newark, CA, USA.
Source: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2025 Apr; Vol. 14 (4), pp. 311-323. Date of Electronic Publication: 2025 Jan 29.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2160-7648 (Electronic) Linking ISSN: 2160763X NLM ISO Abbreviation: Clin Pharmacol Drug Dev Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2160-7648
DOI:10.1002/cpdd.1514